Gadgets
FDA Advisory Panel Unanimously Backs Moderna’s mRNA Influenza Vaccine
FDA advisory committee votes 9-0 to support approval of Moderna’s mRNA seasonal flu vaccine mRNA-1010 (mFlusiva), showing 27% higher efficacy than standard vaccines, after turmoil over Trump appointee’s initial rejection.